|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | |
| A61K 39/00 | |||
| A61K 49/00 | |||
| A61K 49/16 | |||
| A61K 51/10 |
| (11) | Patento numeris | 2807188 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13740871.2 |
| Europos patento paraiškos padavimo data | 2013-01-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-12-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/023307 |
| Data | 2013-01-25 |
| (87) | Numeris | WO 2013/112945 |
| Data | 2013-08-01 |
| (30) | Numeris | Data | Šalis |
| 201261591835 P | 2012-01-27 | US | |
| 201261711207 P | 2012-10-08 | US |
| (72) |
SALDANHA, Jose, GB
NIJJAR, Tarlochan S., US
|
| (73) |
Prothena Biosciences Limited,
77 Sir Rogerson`s Quay Block C Grand Canal Docklands, Dublin 2, D02 T804,
IE
|
| (54) | HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN |
| HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN |